Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Cooper

Showing results (221-230 of 246) with videos related to

Pageof 25
Sort By:
American Journal of Medical Genetics. Part A|February 3, 2004
Targeted scan of fifteen regions for nonsyndromic cleft lip and palate in Filipino familiesR E Schultz, M E Cooper, S Daack-Hirsch, et al.
Journal of Dental Research|June 18, 2015
Spectrum of Dental Phenotypes in Nonsyndromic Orofacial CleftingB J Howe, M E Cooper, A R Vieira, et al.
Diabetologia|May 7, 1999
A novel inhibitor of advanced glycation end-product formation inhibits mesenteric vascular hypertrophy in experimental diabetesT Soulis, S Sastra, V Thallas, et al.
The Journal of Pathology|April 28, 2007
The emerging role of ACE2 in physiology and diseaseI Hamming, M E Cooper, B L Haagmans, et al.
American Journal of Human Genetics|May 1, 1996
Genetic segregation analyses of serum IgG2 levelsM L Marazita, H Lu, M E Cooper, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 1998
Local macrophage and myofibroblast proliferation in progressive renal injury in the rat remnant kidneyN Yang, L L Wu, D J Nikolic-Paterson, et al.
Gut|September 17, 2005
Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2G Paizis, C Tikellis, M E Cooper, et al.
Diabetologia|December 29, 2000
Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetesR E Gilbert, D J Kelly, A J Cox, et al.
Diabetologia|December 3, 2013
Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe(-/-) miceE Di Marco, S P Gray, P Chew, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 21, 2010
Increased risk of cardiovascular disease in Type 1 diabetes: arterial exposure to remnant lipoproteins leads to enhanced deposition of cholesterol and binding to glycated extracellular matrix proteoglycansR Mangat, J W Su, J E Lambert, et al.
Pageof 25

Showing results (221-230 of 246) with videos related to

Sort By:
Pageof 25
American Journal of Medical Genetics. Part A|February 3, 2004
Targeted scan of fifteen regions for nonsyndromic cleft lip and palate in Filipino familiesR E Schultz, M E Cooper, S Daack-Hirsch, et al.
Journal of Dental Research|June 18, 2015
Spectrum of Dental Phenotypes in Nonsyndromic Orofacial CleftingB J Howe, M E Cooper, A R Vieira, et al.
Diabetologia|May 7, 1999
A novel inhibitor of advanced glycation end-product formation inhibits mesenteric vascular hypertrophy in experimental diabetesT Soulis, S Sastra, V Thallas, et al.
The Journal of Pathology|April 28, 2007
The emerging role of ACE2 in physiology and diseaseI Hamming, M E Cooper, B L Haagmans, et al.
American Journal of Human Genetics|May 1, 1996
Genetic segregation analyses of serum IgG2 levelsM L Marazita, H Lu, M E Cooper, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 1998
Local macrophage and myofibroblast proliferation in progressive renal injury in the rat remnant kidneyN Yang, L L Wu, D J Nikolic-Paterson, et al.
Gut|September 17, 2005
Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2G Paizis, C Tikellis, M E Cooper, et al.
Diabetologia|December 29, 2000
Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetesR E Gilbert, D J Kelly, A J Cox, et al.
Diabetologia|December 3, 2013
Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe(-/-) miceE Di Marco, S P Gray, P Chew, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 21, 2010
Increased risk of cardiovascular disease in Type 1 diabetes: arterial exposure to remnant lipoproteins leads to enhanced deposition of cholesterol and binding to glycated extracellular matrix proteoglycansR Mangat, J W Su, J E Lambert, et al.
Pageof 25